Connecting Cohorts to Diminish Alzheimer’s Disease (CONCORD-AD): A report of an International Research Collaboration Network
Manuscript Number:
21-0525R1
Author(s):
Samantha C. Burnham, Lesley M. Butler, Preciosa M. Coloma, Jean-François Dartigues, Rachelle S. Doody, Oskar Hansson, Catherine Helmer, Joseph S. Kass, Colin L. Masters, Sebastian Palmqvist, Valory Pavlik, Karine Peres, Ronald C. Petersen, Mary Sano, Erik Stomrud, Xavier Teitsma, Maria Vassilaki
Disclosures
Samantha C. Burnham
Patents/Royalties
Method for detection of a neurological disease: https://scholar.google.com/citations?view_op=view_citation&hl=en&user=5KxzR2EAAAAJ&cstart=100&pagesize=100&sortby=pubdate&citation_for_view=5KxzR2EAAAAJ:LgRImbQfgY4C
SC Burnham, N Faux, SM Laws
US Patent App. 14/116,114
Lesley M. Butler
Sponsors:
Employee of F. Hoffmann-La Roche Ltd.
Preciosa M. Coloma
Sponsors:
Employee of F. Hoffmann-La Roche Ltd.
Jean-François Dartigues
Nothing to Disclose
Rachelle S. Doody
Equity:
Owns stock in F. Hoffmann-La Roche Ltd.
Sponsors:
Employee of Genentech Inc., part of F. Hoffmann-La Roche, Ltd.
Oskar Hansson
Grants
Agency:
F. Hoffmann-La Roche
Dates:
Jan 1, 2018
Agency:
Pfizer
Dates:
Jan 1, 2017
Agency:
GE Healthcare
Dates:
Jan 1, 2018
Agency:
Biogen
Dates:
Dec 1, 2020
Agency:
AVID Radiopharmaceuticals
Dates:
Jan 1 2014
Agency:
Euroimmun
Dates:
Jan 1, 2016
Catherine Helmer
Nothing to Disclose
Joseph S. Kass
Nothing to Disclose
Colin L. Masters
Nothing to Disclose
Sebastian Palmqvist
Nothing to Disclose
Valory Pavlik
Nothing to Disclose
Karine Peres
Nothing to Disclose
Ronald C. Petersen
Consulting Fees:
Consultant for Roche, Inc., Merck, Inc., Biogen, Inc., Eisai, inc. and has served on a DSMB for Genentech, Inc.
Patents/Royalties
Receives royalties from Oxford University Press and UpToDate.
Mary Sano
Nothing to Disclose
Erik Stomrud
Nothing to Disclose
Xavier Teitsma
Sponsors:
Employee of F. Hoffmann-La Roche Ltd.
Maria Vassilaki
Consulting Fees:
currently consult for F. Hoffmann-La Roche on analysis of data and interpretation (started 01/2021), and have received up to the present $4900; payments are submitted to my institution.
Equity:
Equity ownership in Abbott Laboratories, Johnson and Johnson, Medtronic, and Amgen